Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation

医学 胺碘酮 拜瑞妥 阿哌沙班 心房颤动 内科学 华法林 心脏病学 冲程(发动机) 达比加群 大出血 麻醉 机械工程 工程类
作者
Wayne A. Ray,Cecilia P. Chung,C. Michael Stein,Walter Smalley,Eli E. Zimmerman,William D. Dupont,Adriana M. Hung,James R. Daugherty,Alyson L. Dickson,Katherine T. Murray
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:176 (6): 769-778 被引量:13
标识
DOI:10.7326/m22-3238
摘要

Amiodarone, the most effective antiarrhythmic drug in atrial fibrillation, inhibits apixaban and rivaroxaban elimination, thus possibly increasing anticoagulant-related risk for bleeding. For patients receiving apixaban or rivaroxaban, to compare risk for bleeding-related hospitalizations during treatment with amiodarone versus flecainide or sotalol, antiarrhythmic drugs that do not inhibit these anticoagulants' elimination. Retrospective cohort study. U.S. Medicare beneficiaries aged 65 years or older. Patients with atrial fibrillation began anticoagulant use between 1 January 2012 and 30 November 2018 and subsequently initiated treatment with study antiarrhythmic drugs. Time to event for bleeding-related hospitalizations (primary outcome) and ischemic stroke, systemic embolism, and death with or without recent (past 30 days) evidence of bleeding (secondary outcomes), adjusted with propensity score overlap weighting. There were 91 590 patients (mean age, 76.3 years; 52.5% female) initiating use of study anticoagulants and antiarrhythmic drugs, 54 977 with amiodarone and 36 613 with flecainide or sotalol. Risk for bleeding-related hospitalizations increased with amiodarone use (rate difference [RD], 17.5 events [95% CI, 12.0 to 23.0 events] per 1000 person-years; hazard ratio [HR], 1.44 [CI, 1.27 to 1.63]). Incidence of ischemic stroke or systemic embolism did not increase (RD, -2.1 events [CI, -4.7 to 0.4 events] per 1000 person-years; HR, 0.80 [CI, 0.62 to 1.03]). The risk for death with recent evidence of bleeding (RD, 9.1 events [CI, 5.8 to 12.3 events] per 1000 person-years; HR, 1.66 [CI, 1.35 to 2.03]) was greater than that for other deaths (RD, 5.6 events [CI, 0.5 to 10.6 events] per 1000 person-years; HR, 1.15 [CI, 1.00 to 1.31]) (HR comparison: P = 0.003). The increased incidence of bleeding-related hospitalizations for rivaroxaban (RD, 28.0 events [CI, 18.4 to 37.6 events] per 1000 person-years) was greater than that for apixaban (RD, 9.1 events [CI, 2.8 to 15.3 events] per 1000 person-years) (P = 0.001). Possible residual confounding. In this retrospective cohort study, patients aged 65 years or older with atrial fibrillation treated with amiodarone during apixaban or rivaroxaban use had greater risk for bleeding-related hospitalizations than those treated with flecainide or sotalol. National Heart, Lung, and Blood Institute.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
勤劳的乐安完成签到,获得积分10
1秒前
kitty发布了新的文献求助20
2秒前
kiltorh完成签到,获得积分10
2秒前
Orange应助平常的路人采纳,获得10
2秒前
3秒前
风犬少年完成签到,获得积分10
3秒前
3秒前
懒懒洋洋洋完成签到 ,获得积分10
3秒前
4秒前
詹密完成签到,获得积分10
4秒前
积极含羞草完成签到,获得积分10
5秒前
故事的小红花完成签到,获得积分10
5秒前
QWDSA完成签到,获得积分10
6秒前
龙华之士发布了新的文献求助10
7秒前
7秒前
北冥有鱼完成签到,获得积分10
9秒前
Yddear发布了新的文献求助10
9秒前
manfullmoon完成签到,获得积分10
9秒前
鲨鱼也蛀牙完成签到,获得积分10
9秒前
Dragon完成签到 ,获得积分10
9秒前
9秒前
李健应助小王采纳,获得10
10秒前
云轩完成签到,获得积分10
12秒前
顾矜应助王铂然采纳,获得10
13秒前
13秒前
13秒前
岩下松风完成签到,获得积分10
14秒前
zzzyyyuuu完成签到 ,获得积分10
14秒前
默默白桃完成签到 ,获得积分10
14秒前
hbsand完成签到,获得积分10
16秒前
cao完成签到 ,获得积分10
17秒前
Jasper应助fanicky采纳,获得10
17秒前
Yddear完成签到,获得积分10
17秒前
18秒前
21秒前
彩色的芷烟完成签到,获得积分10
21秒前
无心的平蝶完成签到,获得积分10
21秒前
22秒前
24秒前
yaoyh_gc完成签到,获得积分10
24秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038446
求助须知:如何正确求助?哪些是违规求助? 3576149
关于积分的说明 11374627
捐赠科研通 3305875
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892680
科研通“疑难数据库(出版商)”最低求助积分说明 815048